Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Biopharmacon, AB

Closing information (x1000 DKK)

Closing information 2025/06 2024/06 2023/06
Turnover 245 More Arrow 315 Less Arrow 241
Financial expenses 2 More Arrow 3 Less Arrow 0
Earnings before taxes 66 More Arrow 148 Less Arrow 13
EBITDA -35 More Arrow 41 Less Arrow -22
Total assets 4,709 Less Arrow 4,645 Less Arrow 4,299
Current assets 4,433 Less Arrow 4,372 Less Arrow 4,033
Current liabilities 63 More Arrow 109 Less Arrow 54
Equity capital 4,619 Less Arrow 4,481 Less Arrow 4,200
- share capital 67 Less Arrow 66 Less Arrow 63
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2025/06 2024/06 2023/06
Solvency 98.1% Less Arrow 96.5% More Arrow 97.7%
Turnover per employee 245 More Arrow 315 Less Arrow 241
Profit as a percentage of turnover 26.9% More Arrow 47.0% Less Arrow 5.4%
Return on assets (ROA) 1.4% More Arrow 3.3% Less Arrow 0.3%
Current ratio 7036.5% Less Arrow 4011.0% More Arrow 7468.5%
Return on equity (ROE) 1.4% More Arrow 3.3% Less Arrow 0.3%
Change turnover -76 More Arrow 64 More Arrow 88
Change turnover % -24% More Arrow 26% More Arrow 57%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2025/06 2024/06 2023/06
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.